{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:38:56Z","timestamp":1792665536886,"version":"4.5.0"},"reference-count":31,"publisher":"e-Century Publishing Corporation","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/gdxh3501","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:31:51Z","timestamp":1767148311000},"page":"9566-9579","source":"Crossref","is-referenced-by-count":1,"title":["Association between delayed methotrexate metabolism, coagulation function, and adverse reactions in patients with acute lymphoblastic leukemia receiving high-dose methotrexate treatment"],"prefix":"10.62347","volume":"17","author":[{"given":"Jing","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00428-022-03448-8","article-title":"International Consensus Classification of acute lymphoblastic leukemia\/lymphoma","volume":"482","author":"AS","year":"2023","unstructured":"Duffield AS, Mullighan CG and Borowitz MJ. International Consensus Classification of acute lymphoblastic leukemia\/lymphoma. Virchows Arch 2023; 482: 11-26.","journal-title":"Virchows Arch"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","article-title":"Pediatric acute lymphoblastic leukemia","volume":"105","author":"Inaba","year":"2020","unstructured":"Inaba H and Mullighan CG. Pediatric acute lymphoblastic leukemia. Haematologica 2020; 105: 2524-2539.","journal-title":"Haematologica"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","article-title":"Acute lymphoblastic leukaemia","volume":"395","author":"Malard","year":"2020","unstructured":"Malard F and Mohty M. Acute lymphoblastic leukaemia. Lancet 2020; 395: 1146-1162.","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"DeAngelo DJ, Jabbour E and Advani A. Recent advances in managing acute lymphoblastic leukemia. Am Soc Clin Oncol Educ Book 2020; 40: 330-342.","DOI":"10.1200\/EDBK_280175"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s11684-020-0759-8","article-title":"Precision medicine in acute lymphoblastic leukemia","volume":"14","author":"Pui","year":"2020","unstructured":"Pui CH. Precision medicine in acute lymphoblastic leukemia. Front Med 2020; 14: 689-700.","journal-title":"Front Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1003812","DOI":"10.3389\/fphar.2022.1003812","article-title":"Association between high-dose methotrexate-induced toxicity and polymorphisms within methotrexate pathway genes in acute lymphoblastic leukemia","volume":"13","author":"Xu","year":"2022","unstructured":"Xu M, Wu S, Wang Y, Zhao Y, Wang X, Wei C, Liu X, Hao F and Hu C. Association between high-dose methotrexate-induced toxicity and polymorphisms within methotrexate pathway genes in acute lymphoblastic leukemia. Front Pharmacol 2022; 13: 1003812.","journal-title":"Front Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1200\/JCO.22.01760","article-title":"Childhood acute lymphoblastic leukemia: results of the randomized acute lymphoblastic leukemia intercontinental-berlin-Frankfurt-Münster 2009 trial","volume":"41","author":"Campbell","year":"2023","unstructured":"Campbell M, Kiss C, Zimmermann M, Riccheri C, Kowalczyk J, Felice MS, Kuzmanovic M, Kovacs G, Kosmidis H, Gonzalez A, Bilic E, Castillo L, Kolenova A, Jazbec J, Popa A, Konstantinov D, Kappelmayer J, Szczepanski T, Dworzak M, Buldini B, Gaipa G, Marinov N, Rossi J, Nagy A, Gaspar I, Stary J and Schrappe M. Childhood acute lymphoblastic leukemia: results of the randomized acute lymphoblastic leukemia intercontinental-berlin-Frankfurt-Münster 2009 trial. J Clin Oncol 2023; 41: 3499-3511.","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00280-024-04694-0","article-title":"Systematic review: genetic polymorphisms in the pharmacokinetics of high-dose methotrexate in pediatric acute lymphoblastic leukemia patients","volume":"94","author":"SU","year":"2024","unstructured":"Rahmayanti SU, Amalia R and Rusdiana T. Systematic review: genetic polymorphisms in the pharmacokinetics of high-dose methotrexate in pediatric acute lymphoblastic leukemia patients. Cancer Chemother Pharmacol 2024; 94: 141-155.","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"110607","DOI":"10.1016\/j.celrep.2022.110607","article-title":"NADPH metabolism determines the leukemogenic capacity and drug resistance of AML cells","volume":"39","author":"Chen","year":"2022","unstructured":"Chen C, Lai X, Zhang Y, Xie L, Yu Z, Dan S, Jiang Y, Chen W, Liu L, Yang Y, Huang D, Zhao Y and Zheng J. NADPH metabolism determines the leukemogenic capacity and drug resistance of AML cells. Cell Rep 2022; 39: 110607.","journal-title":"Cell Rep"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"118907","DOI":"10.1016\/j.lfs.2020.118907","article-title":"The effects of drug transporters on the efficacy of methotrexate in the treatment of rheumatoid arthritis","volume":"268","author":"Gao","year":"2021","unstructured":"Gao J, Wang C and Wei W. The effects of drug transporters on the efficacy of methotrexate in the treatment of rheumatoid arthritis. Life Sci 2021; 268: 118907.","journal-title":"Life Sci"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/17425255.2024.2332366","article-title":"Risk factors associated with high-dose methotrexate induced toxicities","volume":"20","author":"Li","year":"2024","unstructured":"Li W, Mo J, Yang Z, Zhao Z and Mei S. Risk factors associated with high-dose methotrexate induced toxicities. Expert Opin Drug Metab Toxicol 2024; 20: 263-274.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.apsb.2019.12.003","article-title":"Xenobiotic receptors in mediating the effect of sepsis on drug metabolism","volume":"10","author":"Lv","year":"2020","unstructured":"Lv C and Huang L. Xenobiotic receptors in mediating the effect of sepsis on drug metabolism. Acta Pharm Sin B 2020; 10: 33-41.","journal-title":"Acta Pharm Sin B"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Granados JC, Ermakov V, Maity K, Vera DR, Chang G and Nigam SK. The kidney drug transporter OAT1 regulates gut microbiome-dependent host metabolism. JCI Insight 2023; 8: e160437.","DOI":"10.1172\/jci.insight.160437"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s40620-023-01567-2","article-title":"Acute kidney injury following methotrexate treatment","volume":"36","author":"Donaldson Dasgupta","year":"2023","unstructured":"Donaldson Dasgupta A, Schretlen C, Atta MG and Arend LJ. Acute kidney injury following methotrexate treatment. J Nephrol 2023; 36: 1447-1450.","journal-title":"J Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1007\/s00210-024-03567-w","article-title":"Dabigatran attenuates methotrexate-induced hepatotoxicity by regulating coagulation, endothelial dysfunction, and the NF-kB\/IL-1β\/MCP-1 and TLR4\/NLRP3 signaling pathways","volume":"398","author":"El-Dessouki","year":"2025","unstructured":"El-Dessouki AM, Alzokaky AA, Raslan NA, Ibrahim S, Selim H and Al-Karmalawy AA. Dabigatran attenuates methotrexate-induced hepatotoxicity by regulating coagulation, endothelial dysfunction, and the NF-kB\/IL-1β\/MCP-1 and TLR4\/NLRP3 signaling pathways. Naunyn Schmiedebergs Arch Pharmacol 2025; 398: 5129-5145.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.asjsur.2021.02.004","article-title":"Continuous renal replacement therapy in sepsis-associated acute kidney injury: effects on inflammatory mediators and coagulation function","volume":"44","author":"Wu","year":"2021","unstructured":"Wu S, Xu T, Wu C, Lei X and Tian X. Continuous renal replacement therapy in sepsis-associated acute kidney injury: effects on inflammatory mediators and coagulation function. Asian J Surg 2021; 44: 1254-1259.","journal-title":"Asian J Surg"},{"key":"ref16","unstructured":"Qu JM and Cao B. Guidelines for the diagnosis and treatment of adult community acquired pneumonia in China (2016 Edition). Zhonghua Jie He He Hu Xi Za Zhi 2016; 39: 241-242."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00280-024-04687-z","article-title":"Development of a novel nomogram for predicting delayed methotrexate excretion following high-dose methotrexate in adult patients with hematologic malignancies","volume":"94","author":"Ikeda","year":"2024","unstructured":"Ikeda D, Isezaki T, Narita K, Yuyama S, Oura M, Uehara A, Tabata R, Takeuchi M and Matsue K. Development of a novel nomogram for predicting delayed methotrexate excretion following high-dose methotrexate in adult patients with hematologic malignancies. Cancer Chemother Pharmacol 2024; 94: 397-406.","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"5376","DOI":"10.1200\/JCO.23.00365","article-title":"High-dose methotrexate as CNS prophylaxis in high-risk aggressive B-cell lymphoma","volume":"41","author":"KL","year":"2023","unstructured":"Lewis KL, Jakobsen LH, Villa D, Smedby KE, Savage KJ, Eyre TA, Cwynarski K, Bishton MJ, Fox CP, Hawkes EA, Maurer MJ, El-Galaly TC and Cheah CY; International CNS Prophylaxis Study Group. High-dose methotrexate as CNS prophylaxis in high-risk aggressive B-cell lymphoma. J Clin Oncol 2023; 41: 5376-5387.","journal-title":"J Clin Oncol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.21037\/tp-22-671","article-title":"Relationship between methylenetetrahydrofolate reductase gene polymorphisms and methotrexate drug metabolism and toxicity","volume":"12","author":"Tan","year":"2023","unstructured":"Tan Y, Kong Q, Li X, Tang Y, Mai H, Zhen Z, Zhou D and Chen H. Relationship between methylenetetrahydrofolate reductase gene polymorphisms and methotrexate drug metabolism and toxicity. Transl Pediatr 2023; 12: 31-45.","journal-title":"Transl Pediatr"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13741-024-00372-0","article-title":"Comparison of metabolic rates of ropivacaine in cerebrospinal fluid as inferred from plasma concentrations between elderly patients and young patients","volume":"13","author":"Lu","year":"2024","unstructured":"Lu D, Cai F, Ming Y, Zhang D, Ba D, Wu Z and Zhang Z. Comparison of metabolic rates of ropivacaine in cerebrospinal fluid as inferred from plasma concentrations between elderly patients and young patients. Perioper Med (Lond) 2024; 13: 16.","journal-title":"Perioper Med (Lond)"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jare.2024.10.038","article-title":"Genetic associations of metabolic factors and therapeutic drug targets with polycystic ovary syndrome","volume":"75","author":"Zhang","year":"2025","unstructured":"Zhang C, Li Y, Wang Y, Hu S, Liu Y, Liang X, Chen ZJ, Zhang Y and Zhao H. Genetic associations of metabolic factors and therapeutic drug targets with polycystic ovary syndrome. J Adv Res 2025; 75: 581-590.","journal-title":"J Adv Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.21873\/invivo.12185","article-title":"Risk factors for delayed elimination of methotrexate in children, adolescents and young adults with osteosarcoma","volume":"34","author":"Misaka","year":"2020","unstructured":"Misaka KO, Suga Y, Staub Y, Tsubata A, Shimada T, Sai Y and Matsushita R. Risk factors for delayed elimination of methotrexate in children, adolescents and young adults with osteosarcoma. In Vivo 2020; 34: 3459-3465.","journal-title":"In Vivo"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"300","DOI":"10.21037\/tp-23-615","article-title":"Factors influencing delayed high-dose methotrexate excretion and its correlation with adverse reactions after treatment in children with malignant hematological tumors","volume":"13","author":"Yu","year":"2024","unstructured":"Yu L, Shen J, Li H, Zhang M, Wang Z, Gao Y, Chen J and Li J. Factors influencing delayed high-dose methotrexate excretion and its correlation with adverse reactions after treatment in children with malignant hematological tumors. Transl Pediatr 2024; 13: 300-309.","journal-title":"Transl Pediatr"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1080\/09205063.2024.2366619","article-title":"Design, optimization, and evaluation of methotrexate loaded and albumin coated polymeric nanoparticles","volume":"35","author":"Tiwari","year":"2024","unstructured":"Tiwari G, Patil A, Sethi P, Agrawal A, Ansari VA, Posa MK and Aher VD. Design, optimization, and evaluation of methotrexate loaded and albumin coated polymeric nanoparticles. J Biomater Sci Polym Ed 2024; 35: 2068-2089.","journal-title":"J Biomater Sci Polym Ed"},{"key":"ref25","unstructured":"Mirza MA, D Aruna and Konatam ML. Effect of serum albumin level on high-dose methotrexate induced toxicities in acute lymphoblastic leukemia patients. Int J Health Sci (Qassim) 2023; 17: 3-9."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/MED.0b013e32834041d4","article-title":"Disorders of phosphorus homeostasis","volume":"17","author":"Lee","year":"2010","unstructured":"Lee R and Weber TJ. Disorders of phosphorus homeostasis. Curr Opin Endocrinol Diabetes Obes 2010; 17: 561-567.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Side effects of low-dose methotrexate. Ann Intern Med 2020; 172.","DOI":"10.7326\/P20-0001"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1280587","DOI":"10.3389\/fonc.2023.1280587","article-title":"Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients","volume":"13","author":"Mosleh","year":"2023","unstructured":"Mosleh E, Snyder S, Wu N, Willis DN, Malone R and Hayashi RJ. Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients. Front Oncol 2023; 13: 1280587.","journal-title":"Front Oncol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.2147\/DDDT.S271568","article-title":"Development and validation of UHPLC-MS\/MS Assay for therapeutic drug monitoring of high-dose methotrexate in children with acute lymphoblastic leukemia","volume":"14","author":"Lian","year":"2020","unstructured":"Lian LJ, Lin B, Cui X, He J, Wang Z, Lin XD, Ye WJ, Chen RJ and Sun W. Development and validation of UHPLC-MS\/MS Assay for therapeutic drug monitoring of high-dose methotrexate in children with acute lymphoblastic leukemia. Drug Des Devel Ther 2020; 14: 4835-4843.","journal-title":"Drug Des Devel Ther"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12911-023-02248-7","article-title":"Predicting delayed methotrexate elimination in pediatric acute lymphoblastic leukemia patients: an innovative web-based machine learning tool developed through a multicenter, retrospective analysis","volume":"23","author":"Jian","year":"2023","unstructured":"Jian C, Chen S, Wang Z, Zhou Y, Zhang Y, Li Z, Jian J, Wang T, Xiang T, Wang X, Jia Y, Wang H and Gong J. Predicting delayed methotrexate elimination in pediatric acute lymphoblastic leukemia patients: an innovative web-based machine learning tool developed through a multicenter, retrospective analysis. BMC Med Inform Decis Mak 2023; 23: 148.","journal-title":"BMC Med Inform Decis Mak"}],"container-title":["American Journal of Translational Research"],"original-title":[],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:50:56Z","timestamp":1792662656000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/12\/ajtr0167039.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":31,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/gdxh3501","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}